首页> 外国专利> Insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidated lipid production suppressor, ppar activator, leukotriene antagonist, hydroxydipocellular formation promoter or calcium antagonist, preventive agent and / or therapeutic, carboxylic acid derivatives, medication, pharmaceutical composition, and use of a compound

Insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidated lipid production suppressor, ppar activator, leukotriene antagonist, hydroxydipocellular formation promoter or calcium antagonist, preventive agent and / or therapeutic, carboxylic acid derivatives, medication, pharmaceutical composition, and use of a compound

机译:胰岛素抵抗改善剂,降糖药,免疫调节剂,醛糖还原酶抑制剂,5-脂氧合酶抑制剂,过氧化脂质产生抑制剂,ppar活化剂,白三烯拮抗剂,羟基二足细胞形成促进剂或钙拮抗剂,预防剂和/或治疗剂,羧酸衍生物,药物,药物组合物和化合物的用途

摘要

The alpha -substituted carboxylic acid derivatives having the general formula (I): CHEM Äwherein R1 is an alkyl group, etc., R2 is a hydrogen atom, etc., R3 is a hydrogen atom, etc., A is = CH-group, etc., B is an oxygen atom, etc., W1 is a C1-C8 alkylene group, W2 is a single bond or a C1-C8 alkylene group, X is a hydrogen atom, etc., Y is an oxygen atom, etc., and Z1 is an alkoxy group, etc.Ü, or pharmacologically acceptable salts thereof, pharmacologically acceptable esters thereof or pharmacologically acceptable amides thereof are useful as therapeutic agents and/or preventive agents for diabetes mellitus, glucose tolerance insufficiency, gestational diabetes mellitus, or the like.
机译:具有通式(I)的α-取代的羧酸衍生物:[化学式1]其中R1是烷基等,R2是氢原子等,R3是氢原子等,A是= CH -基等,B为氧原子等,W 1为碳原子数1〜8的亚烷基,W 2为单键或碳原子数1〜8的亚烷基,X为氢原子等,Y为氧Z 1或其药理学上可接受的盐,其药理学上可接受的酯或药理学上可接受的酰胺可用作糖尿病,葡萄糖耐量不足,妊娠期的治疗剂和/或预防剂。糖尿病等。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号